BioSpace News Archive

Biotech Bay

23andMe Launches Total Health™, its Comprehensive, Prevention-Based Health Membership

23andMe Holding Co., a leading genetic health and biopharmaceutical company, launched 23andMe+Total Health, its new, comprehensive prevention-based health membership that provides clinical grade exome sequencing, biannual blood testing, and unprecedented access to genetics-based clinical care.

November 7, 2023
·
11 min read
Business

Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, provided a corporate update and reported financial results for the third quarter ended September 30, 2023.

November 7, 2023
·
12 min read
Business

Belite Bio to Host Webcast on November 14, 2023, to Discuss Third Quarter 2023 Financial Results

Belite Bio, Inc announced that it will host a webcast on Tuesday, November 14, 2023, at 4:30 p.m. Eastern Time to discuss the Company’s financial results for the third quarter ended September 30, 2023, and provide a general business update.

November 7, 2023
·
1 min read
Genetown

Alnylam to Webcast Presentations at Upcoming November Investor Conferences - November 7, 2023

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present company overviews at the following conferences.

November 7, 2023
·
2 min read
Drug Development

ENB Therapeutics Presents Top-line Results from Phase 1b ENBOLDEN-101 Study in Platinum Refractory/ Resistant Ovarian Cancer at SITC 2023

ENB Therapeutics, Inc. today announced top-line results from the dual combination arm of the Phase 1b ENBOLDEN-101 study, evaluating ENB-003 in combination with Merck’s anti-PD-1 therapy KEYTRUDA® (pembrolizumab) in patients with advanced refractory cancers.

November 7, 2023
·
6 min read
Pharm Country

Integral Molecular Launches TiterSafe™ Influenza Virus-Like Particles for Safe and Convenient Vaccine Testing

Integral Molecular, a leading provider of reagents for vaccine evaluation, announces the launch of TiterSafe™ influenza virus-like particles, an off-the-shelf virus-alternative for key experiments in testing influenza vaccines.

November 7, 2023
·
2 min read
BioMidwest

MAIA Biotechnology Reports Third Quarter 2023 Financial Results and Highlights Recent Development Progress for Anticancer Asset THIO

MAIA Biotechnology, Inc. today reported financial results for the third quarter ended September 30, 2023 and key operational updates.

November 7, 2023
·
9 min read
Business

LegoChem Biosciences Selects BostonGene as Genomic Partner for First-in-Human Clinical Trial

BostonGene and LegoChem Biosciences, Inc. announced a collaboration to support the Phase I/II study of LCB84, a TROP2-directed ADC, in patients with advanced cancers.

November 7, 2023
·
4 min read
Pharm Country

PaxMedica Announces Publication of Its Autism Spectrum Disorder Phase 2 Study Results in Peer-reviewed Journal

PaxMedica, Inc. announced the publication of research findings in the Annals of General Psychiatry.

November 7, 2023
·
4 min read
Business

IMUNON to Hold Third Quarter 2023 Financial Results and Business Update Conference Call on Tuesday, November 14, 2023

IMUNON, Inc. announces that the Company will host a conference call at 10:00 a.m. ET on Tuesday, November 14, 2023 to discuss financial results for the third quarter and nine-months ended September 30, 2023.

November 7, 2023
·
3 min read